<VariationArchive RecordType="classified" VariationID="816996" VariationName="NM_001111125.3(IQSEC2):c.797_806dup (p.Tyr269Ter)" VariationType="Duplication" Accession="VCV000816996" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2020-03-16" MostRecentSubmission="2020-03-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="806236" VariationID="816996">
      <GeneList>
        <Gene Symbol="IQSEC2" FullName="IQ motif and Sec7 domain ArfGEF 2" GeneID="23096" HGNC_ID="HGNC:29059" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp11.22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="53225813" stop="53321350" display_start="53225813" display_stop="53321350" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="53262057" stop="53350521" display_start="53262057" display_stop="53350521" Strand="-" />
          </Location>
          <OMIM>300522</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-07" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IQSEC2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-07" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IQSEC2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001111125.3(IQSEC2):c.797_806dup (p.Tyr269Ter)</Name>
      <CanonicalSPDI>NC_000023.11:53255992:TAGGGGGGTT:TAGGGGGGTTTAGGGGGGTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.22</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="53255992" stop="53255993" display_start="53255992" display_stop="53255993" variantLength="10" positionVCF="53255992" referenceAlleleVCF="G" alternateAlleleVCF="GTAGGGGGGTT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="53285174" stop="53285175" display_start="53285174" display_stop="53285175" variantLength="10" positionVCF="53285174" referenceAlleleVCF="G" alternateAlleleVCF="GTAGGGGGGTT" />
      </Location>
      <ProteinChange>Y269*</ProteinChange>
      <ProteinChange>Y64*</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.53285175_53285184dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.53285175_53285184dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.53255993_53256002dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.53255993_53256002dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_021296.2" sequenceAccession="NG_021296" sequenceVersion="2" change="g.70349_70358dup">
            <Expression>NG_021296.2:g.70349_70358dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001111125.3" sequenceAccession="NM_001111125" sequenceVersion="3" change="c.797_806dup" MANESelect="true">
            <Expression>NM_001111125.3:c.797_806dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001104595.1" sequenceAccession="NP_001104595" sequenceVersion="1" change="p.Tyr269Ter">
            <Expression>NP_001104595.1:p.Tyr269Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015075.2" sequenceAccession="NM_015075" sequenceVersion="2" change="c.182_191dup">
            <Expression>NM_015075.2:c.182_191dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055890.1" sequenceAccession="NP_055890" sequenceVersion="1" change="p.Tyr64Ter">
            <Expression>NP_055890.1:p.Tyr64Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1194" sequenceAccession="LRG_1194">
            <Expression>LRG_1194:g.70349_70358dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1194t1" sequenceAccession="LRG_1194t1">
            <Expression>LRG_1194t1:c.797_806dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1194p1" sequenceAccession="LRG_1194p1" change="p.Tyr269Ter">
            <Expression>LRG_1194p1:p.Tyr269Ter</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1602293823" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001111125.3(IQSEC2):c.797_806dup (p.Tyr269Ter) AND not provided" Accession="RCV001008036" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-12-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-03-16" MostRecentSubmission="2020-03-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2305762" SubmissionDate="2019-10-15" DateLastUpdated="2020-03-16" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDX:436064|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001167769" DateUpdated="2020-03-16" DateCreated="2020-03-16" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-12-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The IQSEC2 gene encodes a guanine nucleotide exchange factor for the ARF family of GTP-binding proteins (MIM: 300522). Variants in the IQSEC2 gene have been reported to co-segregate with an intellectual disability phenotype in several families with multiple affected male relatives (Shoubridge et al., 2010; Rauch et al., 2012). In one study, males with IQSEC2 variants were described to have moderate to severe intellectual disability and some had additional features of autistic traits, seizures, psychiatric problems and delayed language skills, although the combination of features was noted to vary among families (Shoubridge et al., 2010). A more recent study identified de novo truncating IQSEC2 variants in two severely affected unrelated males with developmental delay, seizures, hypotonia, plagiocephaly, and abnormal MRI findings (Gandomi et al., 2013). Phenotypic variability has also been observed in females with heterozygous IQSEC2 variants. In one study of X-linked intellectual disability, heterozygous females were generally asymptomatic, although some exhibited learning problems (Shoubridge et al., 2010). In contrast, an exome sequencing study of individuals with epileptic encephalopathy identified de novo IQSEC2 nonsense mutations in two females with seizures, developmental delay, and mild to moderate intellectual disability (Epi4K Consortium, 2013). The majority of pathogenic variants in IQSEC2 reported to date have been missense and nonsense variants, however one small deletion has also been reported according to the Human Gene Mutation Database (Stenson et al., 2014).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IQSEC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001111125.1:c.797_806dupAACCCCCCTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2305762" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

